Dyne Therapeutics Inc.
DYN | NASDAQ
$17.12
+$0.01 (+0.06%)
At close: Sep 21, 2026, 4:00 PM ET
$17.35
+$0.23 (+1.34%)
Pre-market:
Sep 22, 2026, 6:01 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.05M | 2.24M | 2.46M | n/a | n/a | 700K |
Gross Profit | -2.05M | -2.24M | -2.46M | n/a | n/a | -700K |
Operating Income | -468.18M | -343.89M | -242.16M | -170.96M | -150.03M | -58.65M |
Interest Income | 29.86M | 26.92M | 7.64M | 2.92M | 742K | 56K |
Pretax Income | -446.21M | -317.42M | -235.94M | -168.1M | -149.29M | -59.44M |
Net Income | -446.21M | -317.42M | -235.94M | -168.1M | -149.29M | -58.74M |
Selling & General & Admin | 69.85M | 62.48M | 31.4M | 28.2M | 28.72M | 12.75M |
Research & Development | 398.33M | 281.41M | 210.76M | 142.76M | 121.31M | 45.2M |
Other Expenses | n/a | -2.24M | -2.46M | n/a | n/a | n/a |
Operating Expenses | 466.14M | 341.64M | 239.7M | 170.96M | 150.03M | 57.95M |
Interest Expense | 6.19M | n/a | n/a | 2.92M | n/a | 396K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 468.18M | 343.89M | 242.16M | 170.96M | 150.03M | 58.65M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -700K |
Shares Outstanding (Basic) | 128.44M | 94.14M | 59.68M | 51.98M | 50.9M | 47.27M |
Shares Outstanding (Diluted) | 128.44M | 94.14M | 59.68M | 51.98M | 50.9M | 47.27M |
EPS (Basic) | -3.47 | -3.37 | -3.95 | -3.23 | -2.93 | -1.24 |
EPS (Diluted) | -3.47 | -3.37 | -3.95 | -3.23 | -2.93 | -1.24 |
EBITDA | -437.97M | -315.18M | -233.48M | -163.5M | -148.2M | -58.34M |
EBIT | -440.02M | -317.42M | -235.94M | -165.18M | -149.29M | -59.04M |
Depreciation & Amortization | 2.05M | 2.24M | 2.46M | 1.68M | 1.09M | 700K |
Add to Watchlist
Select watchlists to add or remove DYN